These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 33368089)

  • 1. Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin.
    Mycroft-West CJ; Su D; Pagani I; Rudd TR; Elli S; Gandhi NS; Guimond SE; Miller GJ; Meneghetti MCZ; Nader HB; Li Y; Nunes QM; Procter P; Mancini N; Clementi M; Bisio A; Forsyth NR; Ferro V; Turnbull JE; Guerrini M; Fernig DG; Vicenzi E; Yates EA; Lima MA; Skidmore MA
    Thromb Haemost; 2020 Dec; 120(12):1700-1715. PubMed ID: 33368089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
    David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
    Molecules; 2021 May; 26(11):. PubMed ID: 34072087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
    Tandon R; Sharp JS; Zhang F; Pomin VH; Ashpole NM; Mitra D; McCandless MG; Jin W; Liu H; Sharma P; Linhardt RJ
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33173010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms.
    Paiardi G; Richter S; Oreste P; Urbinati C; Rusnati M; Wade RC
    J Biol Chem; 2022 Feb; 298(2):101507. PubMed ID: 34929169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin.
    Partridge LJ; Urwin L; Nicklin MJH; James DC; Green LR; Monk PN
    Cells; 2021 Jun; 10(6):. PubMed ID: 34200372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
    Clausen TM; Sandoval DR; Spliid CB; Pihl J; Perrett HR; Painter CD; Narayanan A; Majowicz SA; Kwong EM; McVicar RN; Thacker BE; Glass CA; Yang Z; Torres JL; Golden GJ; Bartels PL; Porell RN; Garretson AF; Laubach L; Feldman J; Yin X; Pu Y; Hauser BM; Caradonna TM; Kellman BP; Martino C; Gordts PLSM; Chanda SK; Schmidt AG; Godula K; Leibel SL; Jose J; Corbett KD; Ward AB; Carlin AF; Esko JD
    Cell; 2020 Nov; 183(4):1043-1057.e15. PubMed ID: 32970989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentosan Polysulfate Inhibits Attachment and Infection by SARS-CoV-2 In Vitro: Insights into Structural Requirements for Binding.
    Bertini S; Alekseeva A; Elli S; Pagani I; Zanzoni S; Eisele G; Krishnan R; Maag KP; Reiter C; Lenhart D; Gruber R; Yates EA; Vicenzi E; Naggi A; Bisio A; Guerrini M
    Thromb Haemost; 2022 Jun; 122(6):984-997. PubMed ID: 35322395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations.
    Tree JA; Turnbull JE; Buttigieg KR; Elmore MJ; Coombes N; Hogwood J; Mycroft-West CJ; Lima MA; Skidmore MA; Karlsson R; Chen YH; Yang Z; Spalluto CM; Staples KJ; Yates EA; Gray E; Singh D; Wilkinson T; Page CP; Carroll MW
    Br J Pharmacol; 2021 Feb; 178(3):626-635. PubMed ID: 33125711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
    Nayak SK
    Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marine sulfated glycans inhibit the interaction of heparin with S-protein of SARS-CoV-2 Omicron XBB variant.
    He P; Song Y; Jin W; Li Y; Xia K; Kim SB; Dwivedi R; Farrag M; Bates J; Pomin VH; Wang C; Linhardt RJ; Dordick JS; Zhang F
    Glycoconj J; 2024 Apr; 41(2):163-174. PubMed ID: 38642280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Utility of Native MS for Understanding the Mechanism of Action of Repurposed Therapeutics in COVID-19: Heparin as a Disruptor of the SARS-CoV-2 Interaction with Its Host Cell Receptor.
    Yang Y; Du Y; Kaltashov IA
    Anal Chem; 2020 Aug; 92(16):10930-10934. PubMed ID: 32678978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-SARS-CoV-2 Activity of Rhamnan Sulfate from
    Song Y; He P; Rodrigues AL; Datta P; Tandon R; Bates JT; Bierdeman MA; Chen C; Dordick J; Zhang F; Linhardt RJ
    Mar Drugs; 2021 Nov; 19(12):. PubMed ID: 34940684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mulberry Component Kuwanon C Exerts Potent Therapeutic Efficacy In Vitro against COVID-19 by Blocking the SARS-CoV-2 Spike S1 RBD:ACE2 Receptor Interaction.
    Kim YS; Kwon EB; Kim B; Chung HS; Choi G; Kim YH; Choi JG
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withanone from
    Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
    Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors.
    Prabhakara C; Godbole R; Sil P; Jahnavi S; Gulzar SE; van Zanten TS; Sheth D; Subhash N; Chandra A; Shivaraj A; Panikulam P; U I; Nuthakki VK; Puthiyapurayil TP; Ahmed R; Najar AH; Lingamallu SM; Das S; Mahajan B; Vemula P; Bharate SB; Singh PP; Vishwakarma R; Guha A; Sundaramurthy V; Mayor S
    PLoS Pathog; 2021 Jul; 17(7):e1009706. PubMed ID: 34252168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tinocordiside from
    Balkrishna A; Pokhrel S; Varshney A
    Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural basis of accelerated host cell entry by SARS-CoV-2†.
    Seyran M; Takayama K; Uversky VN; Lundstrom K; Palù G; Sherchan SP; Attrish D; Rezaei N; Aljabali AAA; Ghosh S; Pizzol D; Chauhan G; Adadi P; Mohamed Abd El-Aziz T; Soares AG; Kandimalla R; Tambuwala M; Hassan SS; Azad GK; Pal Choudhury P; Baetas-da-Cruz W; Serrano-Aroca Á; Brufsky AM; Uhal BD
    FEBS J; 2021 Sep; 288(17):5010-5020. PubMed ID: 33264497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
    Qiao B; Olvera de la Cruz M
    ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.